Hull Associates
Country headquarter:
USA.
Market presence:
EU, US, China, India, Japan, Australia, Canada, Israel, Turkey, Korea, Singapore, Argentina, Brazil and Colombia.
General description:
Hull Associates has an experienced team of in-country expert partners available to help with the commercialization of your product. Our team is experienced in new product launches; designing evidence strategies to increase reimbursement; ensuring the optimal positioning to help pharmaceutical, medical device, and diagnostic products to achieve maximum market success.
Areas of regulatory/reimbursement support:
Hull Associates offers a range of services to support pharmaceutical, medical device, and diagnostics companies achieve and maintain adequate reimbursement overseas. Our services range from basic market assessments to marketing dossiers to hands-on execution of dossier submissions and in-country advocacy efforts.
https://ec.europa.eu/digital-single-market/en/ehealth-and-ageing
The eHealth Hub project has received funding from the European Union’s Horizon 2020
Research and Innovation Programme under Grant Agreement No727683.